TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension

NCT00576251 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

221

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Inflammation Associated With Blepharaconjunctivitis

Interventions

DRUG: Tobramycin 0.3%/Dexamethasone 0.05%
DRUG: TOBRADEX

Sponsor

Alcon Research